GLP-1 News
The latest research, community stories, and updates from across the GLP-1 world.
Yesterday
Effectiveness of GLP-1s Like Ozempic, Wegovy May Depend on Your Genetics - AOL.com
Effectiveness of GLP-1s Like Ozempic, Wegovy May Depend on Your Genetics AOL.com
Menergy GLP-1 for Men Evaluated: Compounded Semaglutide and Tirzepatide Program Reviewed - ACCESS Newswire
Menergy GLP-1 for Men Evaluated: Compounded Semaglutide and Tirzepatide Program Reviewed ACCESS Newswire
Earlier
Who needs PTO? Gen Z wants Ozempic on the job - New York Post
Who needs PTO? Gen Z wants Ozempic on the job New York Post
STAT+: FDA eyes expanding testosterone therapy for libido
New research questions GLP-1's purpose, a pancreatic cancer breakthrough, and more biotech news from The Readout
New GLP-1 Side Effect? Highest-Burnout Specialties; Trump's Psychedelic Plan
(MedPage Today) -- Note that some links may require registration or subscription. Another side effect of GLP-1 drugs? Anecdotal reports from doctors and patients suggest the…
The deadly consequences of ICE detention
New research challenges what we know about GLP-1s, vaccine skepticism, and more health news from Morning Rounds
STAT+: Pharmalittle: We’re reading about Lilly weight loss pill trial results, slashed U.K. clinical trial times, and more
Scientists whose work led to powerful obesity drugs like Zepbound are now suggesting targeting the GLP-1 hormone is not necessary for effective weight loss
Side-By-Side Pics Of The First Celebrities Who Admitted To Ozempic And GLP-1 Use - Health Digest
Side-By-Side Pics Of The First Celebrities Who Admitted To Ozempic And GLP-1 Use Health Digest
Tirzepatide linked to more lean mass loss than semaglutide - EMJ
Tirzepatide linked to more lean mass loss than semaglutide EMJ
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study - NDTV
Ozempic Might Preserve Lean Body Mass Better Than Mounjaro: Study NDTV
Kailera nets $625M in one of biotech’s biggest-ever IPOs
The high-profile obesity drug developer priced the biotech sector’s biggest offering in years and will use the proceeds to support a portfolio of medicines licensed from China’s…
Weight Loss Drugs: A Double-Edged Sword for Lean Mass - Devdiscourse
Weight Loss Drugs: A Double-Edged Sword for Lean Mass Devdiscourse
STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
Scientists are raising a provocative hypothesis about GLP-1 drugs for obesity: Perhaps targeting the GLP-1 hormone isn't actually necessary to achieve effective weight loss.
Warning issued on how to spot fake Ozempic, Wegovy and Mounjaro - Liverpool Echo
Warning issued on how to spot fake Ozempic, Wegovy and Mounjaro Liverpool Echo
Public health plans should cover Mounjaro for Type 2 diabetes, Canada’s Drug Agency recommends - The Globe and Mail
Public health plans should cover Mounjaro for Type 2 diabetes, Canada’s Drug Agency recommends The Globe and Mail
What Happens When You Stop Ozempic or Mounjaro? New Study Reveals Surprising Weight-Loss Results - Muscle & Fitness
What Happens When You Stop Ozempic or Mounjaro? New Study Reveals Surprising Weight-Loss Results Muscle & Fitness
Ozempic and Wegovy Can Help Reverse Severe Fatty Liver Disease, Suggests Mouse Study - Health and Me
Ozempic and Wegovy Can Help Reverse Severe Fatty Liver Disease, Suggests Mouse Study Health and Me
GLP-1 Wrongful Death Lawsuit Claims Compounder Sold Contaminated Meds - AboutLawsuits.com
GLP-1 Wrongful Death Lawsuit Claims Compounder Sold Contaminated Meds AboutLawsuits.com
Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online - The Conversation
Ads for GLP-1 drugs are flooding the internet – here’s how to know if it’s safe to buy them online The Conversation
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it - NPR
Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it NPR
5 Pharmacist-Backed Tips for Using Zepbound Injections for Weight Loss - GoodRx
5 Pharmacist-Backed Tips for Using Zepbound Injections for Weight Loss GoodRx
Eli Lilly & Co. stock (US5324571083): Is its obesity drug dominance strong enough to unlock new upsi - AD HOC NEWS
Eli Lilly & Co. stock (US5324571083): Is its obesity drug dominance strong enough to unlock new upsi AD HOC NEWS
Tirzepatide and Viagra: What the combination means for metabolic and sexual health - Charles Darwin University
Tirzepatide and Viagra: What the combination means for metabolic and sexual health Charles Darwin University
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development - Reuters
Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development Reuters
Ozempic, Wegovy: Why GLP-1 Drugs Don't Work for Everyone - Healthline
Ozempic, Wegovy: Why GLP-1 Drugs Don't Work for Everyone Healthline
Younger Indians without diabetes lose weight faster on GLP-1 shots. - en.etemaaddaily.com
Younger Indians without diabetes lose weight faster on GLP-1 shots. en.etemaaddaily.com
Meal Monotony for Weight Loss; Genes Explain GLP-1 Response; Menopause Drug Boom
(MedPage Today) -- Eating the same meals every day may aid in weight loss, according to a study of real-time food tracking data. (Health Psychology) The prevalence of youth-onset…
A VA Clinic Gave Veterans GLP-1s for Weight Loss. A Year Later, Everything Improved - Military.com
A VA Clinic Gave Veterans GLP-1s for Weight Loss. A Year Later, Everything Improved Military.com
Novo cuts Ozempic, Wegovy prices in India amid generic threat - MSN
Novo cuts Ozempic, Wegovy prices in India amid generic threat MSN
Eli Lilly tests GLP-1 candidate to treat addiction in four clinical trials - medwatch.com
Eli Lilly tests GLP-1 candidate to treat addiction in four clinical trials medwatch.com
Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare - U.S. News & World Report
Thinking About A GLP-1 Drug? Your Genetics Might Determine How Well You'll Fare U.S. News & World Report
The genes that make GLP-1 drugs work (or not) - The Times of India
The genes that make GLP-1 drugs work (or not) The Times of India
Stanford scientists discover “natural Ozempic” without side effects - ScienceDaily
Stanford scientists discover “natural Ozempic” without side effects ScienceDaily
Stanford scientists discover “natural Ozempic” without side effects
A newly discovered molecule could reshape the future of weight loss treatments by mimicking the powerful appetite-suppressing effects of drugs like Ozempic — but without many of…
Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions - The Globe and Mail
Apotex wins tentative FDA approval for generic Ozempic, drug makers await Health Canada decisions The Globe and Mail
Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason - ScienceDaily
Why Ozempic doesn’t work for everyone: Scientists just found a hidden reason ScienceDaily
How To Access Weight Loss Drugs if You Can't Afford Them - Health: Trusted and Empathetic Health and Wellness Information
How To Access Weight Loss Drugs if You Can't Afford Them Health: Trusted and Empathetic Health and Wellness Information
You’ve reached your weight loss goal on GLP-1 medications – what now? - Griffin Daily News
You’ve reached your weight loss goal on GLP-1 medications – what now? Griffin Daily News
You’ve reached your weight loss goal on GLP-1 medications – what now? | Health | walkermn.com - The Pilot Independent
You’ve reached your weight loss goal on GLP-1 medications – what now? | Health | walkermn.com The Pilot Independent
You’ve reached your weight loss goal on GLP-1 medications – what now? - cbs19news.com
You’ve reached your weight loss goal on GLP-1 medications – what now? cbs19news.com
Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire - AOL.com
Eli Lilly Isn't Replacing Zepbound -- It's Building an Obesity Empire AOL.com
Ozempic just got cheap enough to change the world - GNN HD
Ozempic just got cheap enough to change the world GNN HD
Your Genes May Predict How Your Body Reacts To GLP-1s, New Study Says - MindBodyGreen
Your Genes May Predict How Your Body Reacts To GLP-1s, New Study Says MindBodyGreen
Are GLP-1 Drugs Linked to Erectile Dysfunction?
(MedPage Today) -- GLP-1 receptor agonist use may be associated with a modest increase in erectile dysfunction (ED) risk in men with type 2 diabetes, a target trial emulation…
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader - AOL.com
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader AOL.com
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader - 24/7 Wall St.
Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader 24/7 Wall St.
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025 - drugdiscoverytrends.com
Pharma 50: Keytruda holds the top brand slot, but tirzepatide and semaglutide have already passed it at the molecule level in FY2025 drugdiscoverytrends.com
Study uncovers unexpected possible side effects of weight loss drugs - UNILAD
Study uncovers unexpected possible side effects of weight loss drugs UNILAD
STAT+: Pharmalittle: We’re reading about cheap generic obesity drugs in India, high demand for estrogen patches and more
And more pharmaceutical news from the Pharmalot campus via the Pharmalittle newsletter
Divorce boom may follow use of Ozempic and other GLP-1 drugs, experts warn - Fox News
Divorce boom may follow use of Ozempic and other GLP-1 drugs, experts warn Fox News
Potential New GLP-1 Side Effects Surfaced via AI Analysis of Reddit Posts - Everyday Health
Potential New GLP-1 Side Effects Surfaced via AI Analysis of Reddit Posts Everyday Health
Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots - USA Today
Foundayo, Wegovy and how GLP-1 weight-loss pills compare to shots USA Today
AI scans 400,000 Reddit posts to flag overlooked GLP-1 side effects - Medical Xpress
AI scans 400,000 Reddit posts to flag overlooked GLP-1 side effects Medical Xpress
Public warned vs illegally compounded Tirzepatide sold online - Interaksyon
Public warned vs illegally compounded Tirzepatide sold online Interaksyon
Evidence, excitement: In the moment with a GLP-1 expert - UW Homepage
Evidence, excitement: In the moment with a GLP-1 expert UW Homepage
AI-based monitoring reveals protein deficiencies in people taking GLP-1 receptor agonists for weight loss - Medical Xpress
AI-based monitoring reveals protein deficiencies in people taking GLP-1 receptor agonists for weight loss Medical Xpress
Evidence, excitement: In the moment with a GLP-1 expert - UW Medicine | Newsroom
Evidence, excitement: In the moment with a GLP-1 expert UW Medicine | Newsroom
Evidence, excitement: In the moment with a GLP-1 expert - UW Medicine | Newsroom
Evidence, excitement: In the moment with a GLP-1 expert UW Medicine | Newsroom
Wegovy Lawsuit 2025-26 | Gastroparesis & Wegovy Settlements - Sokolove Law
Wegovy Lawsuit 2025-26 | Gastroparesis & Wegovy Settlements Sokolove Law
Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care
(MedPage Today) -- Integrating the most effective obesity treatments into cancer survivorship offers "an unprecedented opportunity" to improve long-term outcomes in cancer,…
Pharmacists Play Central Role in Optimizing Tirzepatide Use for Type 2 Diabetes - Pharmacy Times
Pharmacists Play Central Role in Optimizing Tirzepatide Use for Type 2 Diabetes Pharmacy Times
Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk - BioPharma Dive
Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk BioPharma Dive
Lilly launches GLP-1 pill, kicking off showdown with Novo Nordisk
After winning the battle for injectable obesity medicines, Lilly hopes Foundayo can help it catch up in the oral market, where Novo has a three-month lead.
STAT+: Pharmalittle: We’re reading about top pharma lobbyist stepping down, genes and GLP-1 drugs, and more
Steve Ubl, chief executive of PhRMA, plans to step down at the end of the year, after more than a decade leading the main trade group for brand-name drug makers
STAT+: Genetics may shape GLP-1 outcomes, slightly
The traditional biotech venture model under pressure, PhRMA chief Ubl to exit, and other biotech news from The Readout
Choose Health Launches Comprehensive At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy and Mounjaro Users - PR Newswire
Choose Health Launches Comprehensive At-Home GLP-1 Monitoring Panels for Ozempic, Wegovy and Mounjaro Users PR Newswire
GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More - GoodRx
GLP-1 Drug Savings: A Complete Guide for How to Save on Ozempic, Wegovy, and More GoodRx
Study finds nutritional risks in users of GLP-1 drugs - News-Medical
Study finds nutritional risks in users of GLP-1 drugs News-Medical
If you aren’t losing weight with GLP-1 drugs, this may be one reason why - The Boston Globe
If you aren’t losing weight with GLP-1 drugs, this may be one reason why The Boston Globe
Genetics may help explain why some people don't lose much weight using GLP-1 drugs - PhillyVoice
Genetics may help explain why some people don't lose much weight using GLP-1 drugs PhillyVoice
23andMe Study Finds Genetic Keys to GLP-1 Weight Loss - Mirage News
23andMe Study Finds Genetic Keys to GLP-1 Weight Loss Mirage News
Your DNA May Explain Why Ozempic Worked Better for Your Neighbor Than for You - ScienceBlog.com
Your DNA May Explain Why Ozempic Worked Better for Your Neighbor Than for You ScienceBlog.com
Unlocking the Genetics of GLP-1 Medications: Why Your DNA Matters - 23andMe Blog
Unlocking the Genetics of GLP-1 Medications: Why Your DNA Matters 23andMe Blog
STAT+: 23andMe finds genetic changes appear to help predict response to GLP-1 drugs for weight loss
Changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs — and whether the drugs will cause nausea or vomiting.
Hims & Hers Health stock rises as FDA-approved Wegovy and Ozempic come back to market - Traders Union
Hims & Hers Health stock rises as FDA-approved Wegovy and Ozempic come back to market Traders Union
Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
Novo escalated a GLP-1 pricing war with the launch of its newest obesity medicine. Elsewhere, analysts came to Insmed’s defense and HHS changed the way panelists for a key vaccine…
Ozempic just got cheap enough to change the world - vox.com
Ozempic just got cheap enough to change the world vox.com
If you aren’t losing weight with GLP-1 drugs, this may be one reason why - The Boston Globe
If you aren’t losing weight with GLP-1 drugs, this may be one reason why The Boston Globe
Ozempic Weight Loss Success Varies by DNA - Neuroscience News
Ozempic Weight Loss Success Varies by DNA Neuroscience News
Genetic predictors of GLP1 receptor agonist weight loss and side effects - Nature
Genetic predictors of GLP1 receptor agonist weight loss and side effects Nature
India’s generic semaglutide surge - Chemistry World
India’s generic semaglutide surge Chemistry World
Watch out for vision loss in patients taking GLP-1 agonists, CARM warns - Pharmacy Today
Watch out for vision loss in patients taking GLP-1 agonists, CARM warns Pharmacy Today
GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics
(MedPage Today) -- Novo Nordisk said its semaglutide (Wegovy) pill outperformed recently approved orforglipron (Foundayo) in weight loss and tolerability in an indirect comparison…
Cardiologist Sues UPMC; BP Control in a Rut; GLP-1 Drugs During Pregnancy
(MedPage Today) -- In a whistleblower lawsuit, a prominent cardiologist says he was fired from the University of Pittsburgh Medical Center (UPMC) after reporting racist text…
STAT+: Novo Nordisk launches high-dose Wegovy
Insurers score Medicare Advantage wins, the obesity drug race continues, and other biotech news from The Readout
FDA Approves Foundayo, a Wegovy Alternative GLP-1 Pill for Weight Loss - Healthline
FDA Approves Foundayo, a Wegovy Alternative GLP-1 Pill for Weight Loss Healthline
Key facts: Novo Nordisk Wegovy -50% Ozempic -33% U.S.; Oral Wegovy Used - TradingView — Track All Markets
Key facts: Novo Nordisk Wegovy -50% Ozempic -33% U.S.; Oral Wegovy Used TradingView — Track All Markets
Mounjaro: Tirzepatide's Role in Weight Loss and Diabetes Care - AD HOC NEWS
Mounjaro: Tirzepatide's Role in Weight Loss and Diabetes Care AD HOC NEWS
Gastrointestinal Problems Are Most Common GLP-1 Side Effects, Study Finds - AboutLawsuits.com
Gastrointestinal Problems Are Most Common GLP-1 Side Effects, Study Finds AboutLawsuits.com
Coming off GLP 1s - Medical University of South Carolina (MUSC)
Coming off GLP 1s Medical University of South Carolina (MUSC)
Novo Nordisk Slashes Ozempic, Wegovy Prices in India to Fight Generics - Whalesbook
Novo Nordisk Slashes Ozempic, Wegovy Prices in India to Fight Generics Whalesbook
Can Tirzepatide Cause Depression? What the Data Shows - Ro
Can Tirzepatide Cause Depression? What the Data Shows Ro
Dulaglutide or Tirzepatide? Worldwide Biopharma Changes
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick…
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll - ACCESS Newswire
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll ACCESS Newswire
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll - newswire.com
Joi + Blokes Compounded GLP-1 Review 2026: Semaglutide, Tirzepatide, Pricing, and Everything to Verify Before You Enroll newswire.com
Mounjaro: Eli Lilly's GLP-1 Powerhouse Driving Weight Loss Revolution and Investor Interest in North - AD HOC NEWS
Mounjaro: Eli Lilly's GLP-1 Powerhouse Driving Weight Loss Revolution and Investor Interest in North AD HOC NEWS
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics - Reuters
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics Reuters
9 Foundayo (Orforglipron) Side Effects You Should Know About - GoodRx
9 Foundayo (Orforglipron) Side Effects You Should Know About GoodRx
GLP-1 Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? - Health: Trusted and Empathetic Health and Wellness Information
GLP-1 Pills vs. Shots: Which Is Easier, Cheaper, and More Effective for Weight Loss? Health: Trusted and Empathetic Health and Wellness Information
You Get a GLP-1! You Get a GLP-1! Everybody Gets a GLP-1!
(MedPage Today) -- As a primary care physician and obesity board-certified specialist, I believe that GLP-1s are one of the best medical interventions of all time, right up there…
STAT+: Lilly’s obesity pill enters the oral GLP-1 game, Novo responds
Potential import tariffs on drugs, Foundayo is here-o, and other biotech news from The Readout
Best GLP-1 Programs & Weight Loss Medication Providers - Forbes
Best GLP-1 Programs & Weight Loss Medication Providers Forbes
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison - cnbc.com
Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison cnbc.com
She Lost 100 Pounds on Zepbound. Then Her Insurance Cut Her Off - Business Insider
She Lost 100 Pounds on Zepbound. Then Her Insurance Cut Her Off Business Insider
New GLP-1 Pill Wins Speedy Approval for Weight Loss
(MedPage Today) -- The FDA has approved a second oral GLP-1 receptor agonist for weight loss in adults with obesity or overweight and weight-related comorbidities. A once-daily…
FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill - LiveNOW from FOX
FDA approves Foundayo, Eli Lilly's new GLP-1 obesity pill LiveNOW from FOX
FDA approves Lilly obesity pill, triggering battle with Novo Nordisk
Foundayo could erase the Wegovy pill’s four-month head start as the two drugmakers clash on a debate of efficacy and convenience.
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Eli Lilly’s obesity pill was approved by the FDA, setting it up for fierce competition against Novo Nordisk’s new Wegovy pill.
Ambrosia adds a megaround for obesity drugs
The $100 million Series B round will be used to bring the biotech’s oral GLP-1 into early human testing.
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics - ET BrandEquity
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics ET BrandEquity
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics - WTAQ
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics WTAQ
Novo Nordisk Slashes Ozempic & Wegovy Prices Upto 48% After Patent Cliff - NAVLIN DAILY
Novo Nordisk Slashes Ozempic & Wegovy Prices Upto 48% After Patent Cliff NAVLIN DAILY
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics - KFGO
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics KFGO
Novo Nordisk's diabetes and obesity drugs Ozempic, Wegovy to cost less from today - Fortune India
Novo Nordisk's diabetes and obesity drugs Ozempic, Wegovy to cost less from today Fortune India
A New Form of GLP-1s Could Revolutionize Weight-Loss Treatment (Again)—And It's Available Now - Oprah Daily
A New Form of GLP-1s Could Revolutionize Weight-Loss Treatment (Again)—And It's Available Now Oprah Daily
FDA Approves Eli Lilly’s GLP-1 Pill - WIRED
FDA Approves Eli Lilly’s GLP-1 Pill WIRED
Zepbound Blindness Lawsuit [2026 Update] - robertkinglawfirm.com
Zepbound Blindness Lawsuit [2026 Update] robertkinglawfirm.com
Mounjaro Eye Side Effects Lawsuit [2026 Update] - robertkinglawfirm.com
Mounjaro Eye Side Effects Lawsuit [2026 Update] robertkinglawfirm.com
New GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity - Everyday Health
New GLP-1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity Everyday Health
Novo Nordisk again cuts Ozempic, Wegovy prices by up to 48% in India as generics flood market - ThePrint
Novo Nordisk again cuts Ozempic, Wegovy prices by up to 48% in India as generics flood market ThePrint
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics - whbl.com
Novo Nordisk cuts Ozempic, Wegovy prices in India again to fight cheaper generics whbl.com
Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards
(MedPage Today) -- GLP-1 medications showed a range of potential benefits and safety concerns in an umbrella review of non-cardiometabolic outcomes, though the data quality for…
Heart Risks After GLP-1 Hiatus; TED Drug Success; Top Diabetes Researcher Dies
(MedPage Today) -- A 6-month hiatus in GLP-1 drug use was linked with an increased risk of major adverse cardiovascular events in patients with type 2 diabetes compared with…
What really happens to your weight after stopping Ozempic? Cleveland Clinic study offers answers - Cleveland.com
What really happens to your weight after stopping Ozempic? Cleveland Clinic study offers answers Cleveland.com
Novo Nordisk Cuts Prices of Ozempic and Wegovy in India - Deccan Chronicle
Novo Nordisk Cuts Prices of Ozempic and Wegovy in India Deccan Chronicle
Coronary Stem Cell Study Retracted; GLP-1 Drugs and HCM; Bad Heart Health of Police
(MedPage Today) -- The PREVENT-TAHA8 intracoronary stem cell trial from Iran was officially retracted by The BMJ, months after an expression of concern was first published. Poor…
Novo Nordisk slashes Ozempic, Wegovy prices in India, to fend generic competition - Moneycontrol.com
Novo Nordisk slashes Ozempic, Wegovy prices in India, to fend generic competition Moneycontrol.com
Novo cuts Ozempic, Wegovy prices in India amid generic threat - Seeking Alpha
Novo cuts Ozempic, Wegovy prices in India amid generic threat Seeking Alpha
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge - Invezz
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge Invezz
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge - TradingView
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge TradingView
Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up - Mint
Novo Nordisk slashes Ozempic, Wegovy prices as generic competition heats up Mint
Novo Nordisk Cuts Ozempic, Wegovy Prices by Up to 48% Amid Generic Pressure - outlookbusiness.com
Novo Nordisk Cuts Ozempic, Wegovy Prices by Up to 48% Amid Generic Pressure outlookbusiness.com
Novo Slashes Prices Of Ozempic, Wegovy In India - Business Today
Novo Slashes Prices Of Ozempic, Wegovy In India Business Today
Novo Nordisk slashes price on starting dose of Ozempic and Wegovy by 36 and 48%, respectively - BusinessLine
Novo Nordisk slashes price on starting dose of Ozempic and Wegovy by 36 and 48%, respectively BusinessLine
Weight-loss and diabetes drugs Ozempic and Wegovy see price cuts of up to 48% - India Today
Weight-loss and diabetes drugs Ozempic and Wegovy see price cuts of up to 48% India Today
Novo Nordisk further slashes prices of Ozempic, Wegovy in India to better compete as generics enter - TradingView
Novo Nordisk further slashes prices of Ozempic, Wegovy in India to better compete as generics enter TradingView
Novo Nordisk cuts Ozempic and Wegovy prices by up to 48% as GLP-1 competition intensifies in India - The Economic Times
Novo Nordisk cuts Ozempic and Wegovy prices by up to 48% as GLP-1 competition intensifies in India The Economic Times
As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices - Business Standard
As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices Business Standard
Novo Nordisk Lowers Prices Of Ozempic, Wegovy In India - NDTV Profit
Novo Nordisk Lowers Prices Of Ozempic, Wegovy In India NDTV Profit
Novo Nordisk cuts prices of Ozempic, Wegovy in India again to fend off generics competition - Yahoo Finance
Novo Nordisk cuts prices of Ozempic, Wegovy in India again to fend off generics competition Yahoo Finance
What really happens to your weight after stopping Ozempic? Cleveland Clinic study offers answers - Cleveland.com
What really happens to your weight after stopping Ozempic? Cleveland Clinic study offers answers Cleveland.com
GLP-1 Drugs Pick Up Another Win, This Time in Psoriatic Arthritis
(MedPage Today) -- DENVER -- Adding a GLP-1 agonist to psoriasis medication significantly improved outcomes in patients with psoriatic arthritis (PsA) and overweight or obesity,…
Obesity drugmaker Kailera plans an IPO
The company, led by Ron Renaud, raised $1 billion in venture funding to develop a competitor to Wegovy and Zepbound that’s now in late-stage testing.
Ozempic Is About to Go Generic for Billions of People - The New York Times
Ozempic Is About to Go Generic for Billions of People The New York Times
Do GLP-1s make you sad? Novo Nordisk’s chief scientist is sceptical - AFR
Do GLP-1s make you sad? Novo Nordisk’s chief scientist is sceptical AFR
Ozempic and Wegovy linked to new bone health risks - capetownetc.com
Ozempic and Wegovy linked to new bone health risks capetownetc.com
Factbox-Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - MSN
Factbox-Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy MSN
Lilly’s Taltz plus Zepbound shows efficacy in psoriatic arthritis trial - Investing.com
Lilly’s Taltz plus Zepbound shows efficacy in psoriatic arthritis trial Investing.com
The Ozempic Effect: Wegovy silenced a life time of food noise and diet culture for cancer survivor - ThePost.co.nz
The Ozempic Effect: Wegovy silenced a life time of food noise and diet culture for cancer survivor ThePost.co.nz
Remedy Meds Reviews 2026: Is This GLP-1 Weight Loss Solution Worth It? - Muddy River News
Remedy Meds Reviews 2026: Is This GLP-1 Weight Loss Solution Worth It? Muddy River News
Opinion | Taking Ozempic (or other GLP-1 drugs) isn’t cheating - Star Tribune
Opinion | Taking Ozempic (or other GLP-1 drugs) isn’t cheating Star Tribune
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable - Aidsmap
GLP-1 agonists could be a global game-changer, but need to be accessible and affordable Aidsmap
GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics - The Economic Times
GLP-1 impact: Jefferies sees these 3 stocks as winners in the race for Ozempic, Wegovy generics The Economic Times
Ozempic vs Wegovy: Key Differences, Usage & Weight Loss Effectiveness - Metropolis Healthcare
Ozempic vs Wegovy: Key Differences, Usage & Weight Loss Effectiveness Metropolis Healthcare
13 surprising ways GLP-1s may benefit the body, according to science - The Washington Post
13 surprising ways GLP-1s may benefit the body, according to science The Washington Post
MEDVi Claims Evaluated: Most Affordable Tirzepatide GLP-1 Weight Loss Clinic Online - National Today
MEDVi Claims Evaluated: Most Affordable Tirzepatide GLP-1 Weight Loss Clinic Online National Today
MEDVi Claims Evaluated: Most Affordable Tirzepatide GLP-1 - GlobeNewswire
MEDVi Claims Evaluated: Most Affordable Tirzepatide GLP-1 GlobeNewswire
Can GLP-1 Drugs Prevent Worsening Mental Illness? Perhaps, Study Suggests
(MedPage Today) -- People with pre-existing depression or anxiety were less likely to have mental health worsening while taking a GLP-1 medication, observational Swedish data…
Hims & Hers Health starts selling Novo Nordisk's Wegovy, Ozempic - Seeking Alpha
Hims & Hers Health starts selling Novo Nordisk's Wegovy, Ozempic Seeking Alpha
Wave crashes on obesity drug update; Kodiak’s reboot pays dividends
Wave’s drug, which is meant to improve body composition, disappointed investors but was defended by analysts. Elsewhere, Kodiak’s revived vision loss treatment succeeded in a…
GLP-1 Drugs Like Ozempic, Wegovy May Help Treat Anxiety, Depression - aol.com
GLP-1 Drugs Like Ozempic, Wegovy May Help Treat Anxiety, Depression aol.com
Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage - The Motley Fool
Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage The Motley Fool
Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage - The Globe and Mail
Will Medicare Cover Ozempic or Wegovy in 2026? What Retirees Need to Know About GLP-1 Coverage The Globe and Mail
Why tirzepatide is better than semaglutide, GLP-1 medication guide - USA Today
Why tirzepatide is better than semaglutide, GLP-1 medication guide USA Today
Weight-gain fears after stopping Ozempic unfounded – Cleveland Clinic study - Medical Brief
Weight-gain fears after stopping Ozempic unfounded – Cleveland Clinic study Medical Brief
Despite Novo's Robust Oral Wegovy Launch, Access Remains a Challenge for Obesity Drugs - biospace.com
Despite Novo's Robust Oral Wegovy Launch, Access Remains a Challenge for Obesity Drugs biospace.com
Cut-price fat jabs for £10 a MONTH to launch in India rivalling Wegovy and Ozempic - here's what YOU need to know - The Sun
Cut-price fat jabs for £10 a MONTH to launch in India rivalling Wegovy and Ozempic - here's what YOU need to know The Sun
STAT+: Eli Lilly and the ‘societal obligation’ of GLP-1s
Eli Lilly and the "societal obligation" of GLP-1s, Merck's Terns Pharma purchase, and more biotech news in today's Readout newsletter.
'Fake' Wegovy weight loss jabs set to become widely available in UK within months - The Mirror
'Fake' Wegovy weight loss jabs set to become widely available in UK within months The Mirror
Mounjaro penis growth: what the reports really mean for men chasing metabolic health - nk-osijek.hr
Mounjaro penis growth: what the reports really mean for men chasing metabolic health nk-osijek.hr
As Ozempic costs fall, demand for weight-loss drugs is set to surge - Employee Benefit News
As Ozempic costs fall, demand for weight-loss drugs is set to surge Employee Benefit News
New wave of cut-price generic weight-loss drugs to heat up competition for brand leaders Ozempic and Wegovy - thenationalnews.com
New wave of cut-price generic weight-loss drugs to heat up competition for brand leaders Ozempic and Wegovy thenationalnews.com
Wegovy: FDA Approves Higher Dose Shot for Greater Weight Loss - Healthline
Wegovy: FDA Approves Higher Dose Shot for Greater Weight Loss Healthline
Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025 - drugdiscoverytrends.com
Lilly is now the top pharma company by revenue as Mounjaro (+99%) and Zepbound (+175%) combine for $36.5B in FY2025 drugdiscoverytrends.com
Indian drugmakers roll out cheaper Ozempic, Wegovy copies - bignewsnetwork.com
Indian drugmakers roll out cheaper Ozempic, Wegovy copies bignewsnetwork.com
Obesity Drug Trial Dilemma; Tiny Insulin Pump Cleared; Type 5 Diabetes Deaths
(MedPage Today) -- There's a problem with obesity drug trials: patients often can quickly tell if they're on placebo and drop out to get an effective treatment. (Bloomberg via…
Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds - WFIN
Stopping GLP-1 drugs like Ozempic erodes heart health benefits quickly, new study finds WFIN
Dosio Launches GLP-1 Shot Tracking App for Ozempic, Wegovy, Mounjaro, and Zepbound Users - openPR.com
Dosio Launches GLP-1 Shot Tracking App for Ozempic, Wegovy, Mounjaro, and Zepbound Users openPR.com
Ozempic Generics in India 2026: GLP-1 Drug Manufacturing Race - India Briefing
Ozempic Generics in India 2026: GLP-1 Drug Manufacturing Race India Briefing
How to Get GLP-1s If Insurance Won't Cover It: Your Guide to Affordable Ozempic, Wegovy and Zepbound Costs in 2026 - Health US News
How to Get GLP-1s If Insurance Won't Cover It: Your Guide to Affordable Ozempic, Wegovy and Zepbound Costs in 2026 Health US News
DCGI intensifies crackdown on unauthorised sale of GLP-1 weight-loss drugs - Business Standard
DCGI intensifies crackdown on unauthorised sale of GLP-1 weight-loss drugs Business Standard
Md. GOP pushes $449M Medicaid hike to include Ozempic, Wegovy amid budget woes - Baltimore Sun
Md. GOP pushes $449M Medicaid hike to include Ozempic, Wegovy amid budget woes Baltimore Sun
Md. GOP pushes $449M Medicaid hike to include Ozempic, Wegovy amid budget woes - Hanford Sentinel
Md. GOP pushes $449M Medicaid hike to include Ozempic, Wegovy amid budget woes Hanford Sentinel
Md. GOP pushes $449M Medicaid hike to include Ozempic, Wegovy amid budget woes - The Daily Gazette
Md. GOP pushes $449M Medicaid hike to include Ozempic, Wegovy amid budget woes The Daily Gazette
Mounjaro Tirzepatide: User Reports Emotional Blunting as Hidden Side Effect Amid Weight Loss Success - AD HOC NEWS
Mounjaro Tirzepatide: User Reports Emotional Blunting as Hidden Side Effect Amid Weight Loss Success AD HOC NEWS
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply - Benzinga
India's Generic Wave Hits Ozempic And Wegovy As Prices Drop Sharply Benzinga
Short breaks from GLP-1 drugs may boost heart risk for diabetes patients - Benefits and Pensions Monitor
Short breaks from GLP-1 drugs may boost heart risk for diabetes patients Benefits and Pensions Monitor
Factbox-Indian drugmakers flood market with cheaper versions of Novo’s Ozempic, Wegovy - whbl.com
Factbox-Indian drugmakers flood market with cheaper versions of Novo’s Ozempic, Wegovy whbl.com
Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - The Economic Times
Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy The Economic Times
Mounjaro for Weight Loss: Results, Side Effects and How It Works - US News Health
Mounjaro for Weight Loss: Results, Side Effects and How It Works US News Health
Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - Reuters
Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy Reuters
Factbox-Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - sg.news.yahoo.com
Factbox-Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy sg.news.yahoo.com
Factbox-Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy - MSN
Factbox-Indian drugmakers flood market with cheaper versions of Novo's Ozempic, Wegovy MSN
Ozempic: GLP-1s Linked to 42% Lower Risk of Anxiety, Depression - Healthline
Ozempic: GLP-1s Linked to 42% Lower Risk of Anxiety, Depression Healthline
The Race to Beat Ozempic Is Getting Weird - AOL.com
The Race to Beat Ozempic Is Getting Weird AOL.com
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook - Insider Monkey
Eli Lilly and Company (LLY) Expands Zepbound Access as Pricing Reforms Boost Long-Term Growth Outlook Insider Monkey
FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects - MSN
FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects MSN
Wegovy users have 5x higher vision loss risk than Ozempic, new study finds - MSN
Wegovy users have 5x higher vision loss risk than Ozempic, new study finds MSN
Weight loss drug Ozempic cuts depression, anxiety, and addiction risk - ScienceDaily
Weight loss drug Ozempic cuts depression, anxiety, and addiction risk ScienceDaily